← SynDRA
PF-03463275
SynDRA canonical compound SYN0019944 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SLC6A9 |
|---|
| Mechanism of action | glycine transporter inhibitor |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- SLC6A9 INHIBITOR
- Glycine transporter 1 inhibitor
- glycine transporter inhibitor
Cross-references
Synonyms
- Pf-3463275
- PF-3463275
- RefChem:928936
- PF 03463275
- 3U6T9EE6UX
- UNII-3U6T9EE6UX
- C19H22ClFN4O
- GTPL9057
- orb1905869
- SCHEMBL23815708
- SCHEMBL23815721
- SCHEMBL29765361
- SCHEMBL30679712
- GLXC-15517
- EX-A3501
- BDBM50293564
- HY-10716A
- compound 10 [PMID: 19410451]
- AC-36432
- DA-66613
- FP104276
- KB-79869
- MS-26123
- PF0346275
- CS-0087733
- NS00073310
- PF-0346275
- PF-0346275?
- G13983
- T61564
- W5X
Look up PF-03463275 in the interactive SynDRA portal →